nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRB1—coronary artery disease	0.189	0.63	CbGaD
Lisuride—HTR2A—coronary artery disease	0.111	0.37	CbGaD
Lisuride—HTR1B—Penbutolol—coronary artery disease	0.0721	0.191	CbGbCtD
Lisuride—ADRB1—Penbutolol—coronary artery disease	0.0564	0.149	CbGbCtD
Lisuride—HTR1A—Penbutolol—coronary artery disease	0.0452	0.12	CbGbCtD
Lisuride—ADRB1—Timolol—coronary artery disease	0.0398	0.105	CbGbCtD
Lisuride—CYP3A4—Ticagrelor—coronary artery disease	0.0148	0.0392	CbGbCtD
Lisuride—CYP3A4—Fenofibrate—coronary artery disease	0.0132	0.0349	CbGbCtD
Lisuride—CYP2D6—Niacin—coronary artery disease	0.0109	0.0288	CbGbCtD
Lisuride—CYP3A4—Gemfibrozil—coronary artery disease	0.0105	0.0279	CbGbCtD
Lisuride—CYP2D6—Timolol—coronary artery disease	0.0101	0.0268	CbGbCtD
Lisuride—CYP3A4—Clopidogrel—coronary artery disease	0.00914	0.0242	CbGbCtD
Lisuride—CYP2D6—Captopril—coronary artery disease	0.00891	0.0236	CbGbCtD
Lisuride—CYP2D6—Simvastatin—coronary artery disease	0.00861	0.0228	CbGbCtD
Lisuride—HTR2B—cardial valve—coronary artery disease	0.00853	0.249	CbGeAlD
Lisuride—CYP3A4—Eplerenone—coronary artery disease	0.00849	0.0225	CbGbCtD
Lisuride—CYP2D6—Lovastatin—coronary artery disease	0.00842	0.0223	CbGbCtD
Lisuride—CYP2D6—Pravastatin—coronary artery disease	0.00842	0.0223	CbGbCtD
Lisuride—CYP2D6—Atorvastatin—coronary artery disease	0.00767	0.0203	CbGbCtD
Lisuride—CYP3A4—Enalapril—coronary artery disease	0.00757	0.0201	CbGbCtD
Lisuride—CYP3A4—Rosuvastatin—coronary artery disease	0.00589	0.0156	CbGbCtD
Lisuride—CYP3A4—Ezetimibe—coronary artery disease	0.00589	0.0156	CbGbCtD
Lisuride—CYP3A4—Simvastatin—coronary artery disease	0.00547	0.0145	CbGbCtD
Lisuride—CYP3A4—Pravastatin—coronary artery disease	0.00536	0.0142	CbGbCtD
Lisuride—CYP3A4—Lovastatin—coronary artery disease	0.00536	0.0142	CbGbCtD
Lisuride—CYP3A4—Atorvastatin—coronary artery disease	0.00488	0.0129	CbGbCtD
Lisuride—CYP3A4—Losartan—coronary artery disease	0.00446	0.0118	CbGbCtD
Lisuride—HTR2A—arteriole—coronary artery disease	0.00281	0.0821	CbGeAlD
Lisuride—HTR2A—pulmonary artery—coronary artery disease	0.00184	0.0538	CbGeAlD
Lisuride—HTR2A—sympathetic nervous system—coronary artery disease	0.00179	0.0523	CbGeAlD
Lisuride—HTR2A—vagus nerve—coronary artery disease	0.00174	0.0507	CbGeAlD
Lisuride—HTR2A—vein—coronary artery disease	0.00168	0.049	CbGeAlD
Lisuride—HTR1B—artery—coronary artery disease	0.00142	0.0415	CbGeAlD
Lisuride—HTR1D—artery—coronary artery disease	0.00138	0.0402	CbGeAlD
Lisuride—DRD4—heart—coronary artery disease	0.00128	0.0375	CbGeAlD
Lisuride—HTR2A—autonomic nervous system—coronary artery disease	0.0012	0.0352	CbGeAlD
Lisuride—ADRB1—cardiac ventricle—coronary artery disease	0.00075	0.0219	CbGeAlD
Lisuride—ADRB1—myocardium—coronary artery disease	0.000705	0.0206	CbGeAlD
Lisuride—HTR2A—artery—coronary artery disease	0.000683	0.0199	CbGeAlD
Lisuride—Cabergoline—HTR7—coronary artery disease	0.000579	0.18	CrCbGaD
Lisuride—HTR2A—endothelium—coronary artery disease	0.000577	0.0168	CbGeAlD
Lisuride—ADRA2C—cardiac ventricle—coronary artery disease	0.000565	0.0165	CbGeAlD
Lisuride—ADRA2C—myocardium—coronary artery disease	0.000531	0.0155	CbGeAlD
Lisuride—Cabergoline—ADRB1—coronary artery disease	0.000496	0.154	CrCbGaD
Lisuride—HTR1B—cardiovascular system—coronary artery disease	0.000494	0.0144	CbGeAlD
Lisuride—ADRB1—heart—coronary artery disease	0.000492	0.0144	CbGeAlD
Lisuride—Methysergide—HTR7—coronary artery disease	0.000484	0.15	CrCbGaD
Lisuride—HTR1D—cardiovascular system—coronary artery disease	0.000478	0.014	CbGeAlD
Lisuride—HTR2B—heart—coronary artery disease	0.000471	0.0138	CbGeAlD
Lisuride—ADRB1—cardiovascular system—coronary artery disease	0.000464	0.0136	CbGeAlD
Lisuride—HTR2B—cardiovascular system—coronary artery disease	0.000445	0.013	CbGeAlD
Lisuride—ADRB1—cardiac atrium—coronary artery disease	0.000421	0.0123	CbGeAlD
Lisuride—Cabergoline—ADRB2—coronary artery disease	0.000417	0.13	CrCbGaD
Lisuride—HTR1A—cardiovascular system—coronary artery disease	0.000398	0.0116	CbGeAlD
Lisuride—ADRA2C—heart—coronary artery disease	0.000371	0.0108	CbGeAlD
Lisuride—HTR2B—blood—coronary artery disease	0.000352	0.0103	CbGeAlD
Lisuride—ADRA2C—cardiac atrium—coronary artery disease	0.000317	0.00926	CbGeAlD
Lisuride—ADRA2A—heart—coronary artery disease	0.000296	0.00864	CbGeAlD
Lisuride—Methylergometrine—HTR2A—coronary artery disease	0.000291	0.0906	CrCbGaD
Lisuride—Cabergoline—HTR2A—coronary artery disease	0.000291	0.0906	CrCbGaD
Lisuride—ADRA2C—blood—coronary artery disease	0.000277	0.00808	CbGeAlD
Lisuride—ADRA2A—cardiac atrium—coronary artery disease	0.000253	0.00739	CbGeAlD
Lisuride—HTR2A—heart—coronary artery disease	0.000252	0.00735	CbGeAlD
Lisuride—Methysergide—HTR2A—coronary artery disease	0.000243	0.0756	CrCbGaD
Lisuride—HTR2A—cardiovascular system—coronary artery disease	0.000237	0.00693	CbGeAlD
Lisuride—Pergolide—HTR2A—coronary artery disease	0.000225	0.07	CrCbGaD
Lisuride—ADRA2A—blood—coronary artery disease	0.000221	0.00645	CbGeAlD
Lisuride—HTR2A—blood—coronary artery disease	0.000188	0.00548	CbGeAlD
Lisuride—Ergotamine—HTR2A—coronary artery disease	0.000188	0.0584	CrCbGaD
Lisuride—CYP3A4—blood—coronary artery disease	0.000174	0.00507	CbGeAlD
Lisuride—Immune system disorder—Ramipril—coronary artery disease	0.000171	0.0012	CcSEcCtD
Lisuride—CYP2D6—blood—coronary artery disease	0.000171	0.00499	CbGeAlD
Lisuride—Hallucination—Lisinopril—coronary artery disease	0.000171	0.0012	CcSEcCtD
Lisuride—Mediastinal disorder—Ramipril—coronary artery disease	0.000171	0.0012	CcSEcCtD
Lisuride—Dry mouth—Perindopril—coronary artery disease	0.000171	0.0012	CcSEcCtD
Lisuride—Insomnia—Niacin—coronary artery disease	0.000171	0.0012	CcSEcCtD
Lisuride—Palpitations—Losartan—coronary artery disease	0.00017	0.00119	CcSEcCtD
Lisuride—Feeling abnormal—Simvastatin—coronary artery disease	0.000169	0.00119	CcSEcCtD
Lisuride—Oedema peripheral—Lisinopril—coronary artery disease	0.000169	0.00119	CcSEcCtD
Lisuride—Anorexia—Telmisartan—coronary artery disease	0.000169	0.00118	CcSEcCtD
Lisuride—Confusional state—Perindopril—coronary artery disease	0.000169	0.00118	CcSEcCtD
Lisuride—Decreased appetite—Valsartan—coronary artery disease	0.000169	0.00118	CcSEcCtD
Lisuride—Dyspnoea—Niacin—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Tachycardia—Captopril—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Insomnia—Pravastatin—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Angiopathy—Timolol—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Decreased appetite—Olmesartan—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Cough—Losartan—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Somnolence—Niacin—coronary artery disease	0.000168	0.00118	CcSEcCtD
Lisuride—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000167	0.00117	CcSEcCtD
Lisuride—Fatigue—Valsartan—coronary artery disease	0.000167	0.00117	CcSEcCtD
Lisuride—Immune system disorder—Timolol—coronary artery disease	0.000167	0.00117	CcSEcCtD
Lisuride—Mediastinal disorder—Timolol—coronary artery disease	0.000167	0.00117	CcSEcCtD
Lisuride—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000167	0.00117	CcSEcCtD
Lisuride—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000166	0.00117	CcSEcCtD
Lisuride—Fatigue—Olmesartan—coronary artery disease	0.000166	0.00117	CcSEcCtD
Lisuride—Mental disorder—Ramipril—coronary artery disease	0.000166	0.00116	CcSEcCtD
Lisuride—Dry mouth—Furosemide—coronary artery disease	0.000166	0.00116	CcSEcCtD
Lisuride—Constipation—Valsartan—coronary artery disease	0.000166	0.00116	CcSEcCtD
Lisuride—Dyspnoea—Pravastatin—coronary artery disease	0.000166	0.00116	CcSEcCtD
Lisuride—Constipation—Olmesartan—coronary artery disease	0.000165	0.00116	CcSEcCtD
Lisuride—Malnutrition—Ramipril—coronary artery disease	0.000165	0.00116	CcSEcCtD
Lisuride—Anorexia—Captopril—coronary artery disease	0.000164	0.00115	CcSEcCtD
Lisuride—Nervous system disorder—Perindopril—coronary artery disease	0.000164	0.00115	CcSEcCtD
Lisuride—Decreased appetite—Niacin—coronary artery disease	0.000164	0.00115	CcSEcCtD
Lisuride—Confusional state—Furosemide—coronary artery disease	0.000164	0.00115	CcSEcCtD
Lisuride—Tachycardia—Perindopril—coronary artery disease	0.000163	0.00114	CcSEcCtD
Lisuride—Insomnia—Trandolapril—coronary artery disease	0.000163	0.00114	CcSEcCtD
Lisuride—Anxiety—Losartan—coronary artery disease	0.000163	0.00114	CcSEcCtD
Lisuride—Gastrointestinal disorder—Niacin—coronary artery disease	0.000163	0.00114	CcSEcCtD
Lisuride—Insomnia—Enalapril—coronary artery disease	0.000162	0.00114	CcSEcCtD
Lisuride—Headache—Rosuvastatin—coronary artery disease	0.000162	0.00114	CcSEcCtD
Lisuride—Mental disorder—Timolol—coronary artery disease	0.000162	0.00114	CcSEcCtD
Lisuride—Hyperhidrosis—Perindopril—coronary artery disease	0.000162	0.00113	CcSEcCtD
Lisuride—Decreased appetite—Pravastatin—coronary artery disease	0.000161	0.00113	CcSEcCtD
Lisuride—Asthenia—Fenofibrate—coronary artery disease	0.000161	0.00113	CcSEcCtD
Lisuride—Malnutrition—Timolol—coronary artery disease	0.000161	0.00113	CcSEcCtD
Lisuride—Dyspnoea—Trandolapril—coronary artery disease	0.000161	0.00113	CcSEcCtD
Lisuride—Somnolence—Trandolapril—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Insomnia—Telmisartan—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Dyspnoea—Enalapril—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Fatigue—Pravastatin—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Dry mouth—Losartan—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Somnolence—Enalapril—coronary artery disease	0.00016	0.00112	CcSEcCtD
Lisuride—Nervous system disorder—Furosemide—coronary artery disease	0.000159	0.00112	CcSEcCtD
Lisuride—Anorexia—Perindopril—coronary artery disease	0.000159	0.00112	CcSEcCtD
Lisuride—Feeling abnormal—Olmesartan—coronary artery disease	0.000159	0.00112	CcSEcCtD
Lisuride—Constipation—Pravastatin—coronary artery disease	0.000159	0.00111	CcSEcCtD
Lisuride—Asthenia—Clopidogrel—coronary artery disease	0.000159	0.00111	CcSEcCtD
Lisuride—Confusional state—Losartan—coronary artery disease	0.000158	0.00111	CcSEcCtD
Lisuride—Dyspnoea—Telmisartan—coronary artery disease	0.000158	0.00111	CcSEcCtD
Lisuride—Asthenia—Lovastatin—coronary artery disease	0.000158	0.0011	CcSEcCtD
Lisuride—Somnolence—Telmisartan—coronary artery disease	0.000158	0.0011	CcSEcCtD
Lisuride—Hyperhidrosis—Furosemide—coronary artery disease	0.000157	0.0011	CcSEcCtD
Lisuride—Decreased appetite—Trandolapril—coronary artery disease	0.000157	0.0011	CcSEcCtD
Lisuride—Decreased appetite—Enalapril—coronary artery disease	0.000156	0.00109	CcSEcCtD
Lisuride—Infection—Losartan—coronary artery disease	0.000156	0.00109	CcSEcCtD
Lisuride—Insomnia—Captopril—coronary artery disease	0.000156	0.00109	CcSEcCtD
Lisuride—Angiopathy—Lisinopril—coronary artery disease	0.000156	0.00109	CcSEcCtD
Lisuride—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000156	0.00109	CcSEcCtD
Lisuride—Fatigue—Trandolapril—coronary artery disease	0.000156	0.00109	CcSEcCtD
Lisuride—Anorexia—Furosemide—coronary artery disease	0.000155	0.00109	CcSEcCtD
Lisuride—Fatigue—Enalapril—coronary artery disease	0.000155	0.00109	CcSEcCtD
Lisuride—Mediastinal disorder—Lisinopril—coronary artery disease	0.000155	0.00109	CcSEcCtD
Lisuride—Asthenia—Ezetimibe—coronary artery disease	0.000155	0.00108	CcSEcCtD
Lisuride—Constipation—Trandolapril—coronary artery disease	0.000154	0.00108	CcSEcCtD
Lisuride—Decreased appetite—Telmisartan—coronary artery disease	0.000154	0.00108	CcSEcCtD
Lisuride—Nervous system disorder—Losartan—coronary artery disease	0.000154	0.00108	CcSEcCtD
Lisuride—Constipation—Enalapril—coronary artery disease	0.000154	0.00108	CcSEcCtD
Lisuride—Dyspnoea—Captopril—coronary artery disease	0.000154	0.00108	CcSEcCtD
Lisuride—Somnolence—Captopril—coronary artery disease	0.000153	0.00107	CcSEcCtD
Lisuride—Tachycardia—Losartan—coronary artery disease	0.000153	0.00107	CcSEcCtD
Lisuride—Feeling abnormal—Pravastatin—coronary artery disease	0.000153	0.00107	CcSEcCtD
Lisuride—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000153	0.00107	CcSEcCtD
Lisuride—Fatigue—Telmisartan—coronary artery disease	0.000153	0.00107	CcSEcCtD
Lisuride—Hyperhidrosis—Losartan—coronary artery disease	0.000152	0.00106	CcSEcCtD
Lisuride—Constipation—Telmisartan—coronary artery disease	0.000152	0.00106	CcSEcCtD
Lisuride—Insomnia—Perindopril—coronary artery disease	0.000151	0.00106	CcSEcCtD
Lisuride—Asthenia—Eplerenone—coronary artery disease	0.000151	0.00106	CcSEcCtD
Lisuride—Mental disorder—Lisinopril—coronary artery disease	0.00015	0.00105	CcSEcCtD
Lisuride—Decreased appetite—Captopril—coronary artery disease	0.00015	0.00105	CcSEcCtD
Lisuride—Anorexia—Losartan—coronary artery disease	0.00015	0.00105	CcSEcCtD
Lisuride—Malnutrition—Lisinopril—coronary artery disease	0.00015	0.00105	CcSEcCtD
Lisuride—Dyspnoea—Perindopril—coronary artery disease	0.000149	0.00105	CcSEcCtD
Lisuride—Dizziness—Fenofibrate—coronary artery disease	0.000149	0.00104	CcSEcCtD
Lisuride—Somnolence—Perindopril—coronary artery disease	0.000149	0.00104	CcSEcCtD
Lisuride—Feeling abnormal—Trandolapril—coronary artery disease	0.000149	0.00104	CcSEcCtD
Lisuride—Fatigue—Captopril—coronary artery disease	0.000149	0.00104	CcSEcCtD
Lisuride—Vertigo—Ramipril—coronary artery disease	0.000148	0.00104	CcSEcCtD
Lisuride—Feeling abnormal—Enalapril—coronary artery disease	0.000148	0.00104	CcSEcCtD
Lisuride—Syncope—Ramipril—coronary artery disease	0.000148	0.00104	CcSEcCtD
Lisuride—Asthenia—Simvastatin—coronary artery disease	0.000147	0.00103	CcSEcCtD
Lisuride—Constipation—Captopril—coronary artery disease	0.000147	0.00103	CcSEcCtD
Lisuride—Dizziness—Clopidogrel—coronary artery disease	0.000146	0.00103	CcSEcCtD
Lisuride—Feeling abnormal—Telmisartan—coronary artery disease	0.000146	0.00102	CcSEcCtD
Lisuride—Palpitations—Ramipril—coronary artery disease	0.000146	0.00102	CcSEcCtD
Lisuride—Decreased appetite—Perindopril—coronary artery disease	0.000145	0.00102	CcSEcCtD
Lisuride—Dizziness—Lovastatin—coronary artery disease	0.000145	0.00102	CcSEcCtD
Lisuride—Vertigo—Timolol—coronary artery disease	0.000145	0.00102	CcSEcCtD
Lisuride—Somnolence—Furosemide—coronary artery disease	0.000145	0.00101	CcSEcCtD
Lisuride—Syncope—Timolol—coronary artery disease	0.000145	0.00101	CcSEcCtD
Lisuride—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000144	0.00101	CcSEcCtD
Lisuride—Fatigue—Perindopril—coronary artery disease	0.000144	0.00101	CcSEcCtD
Lisuride—Cough—Ramipril—coronary artery disease	0.000144	0.00101	CcSEcCtD
Lisuride—Constipation—Perindopril—coronary artery disease	0.000143	0.001	CcSEcCtD
Lisuride—Vomiting—Fenofibrate—coronary artery disease	0.000143	0.001	CcSEcCtD
Lisuride—Dizziness—Ezetimibe—coronary artery disease	0.000142	0.000999	CcSEcCtD
Lisuride—Palpitations—Timolol—coronary artery disease	0.000142	0.000999	CcSEcCtD
Lisuride—Feeling abnormal—Captopril—coronary artery disease	0.000142	0.000995	CcSEcCtD
Lisuride—Insomnia—Losartan—coronary artery disease	0.000142	0.000995	CcSEcCtD
Lisuride—Decreased appetite—Furosemide—coronary artery disease	0.000141	0.000991	CcSEcCtD
Lisuride—Headache—Fenofibrate—coronary artery disease	0.000141	0.000988	CcSEcCtD
Lisuride—Cough—Timolol—coronary artery disease	0.000141	0.000986	CcSEcCtD
Lisuride—Vomiting—Clopidogrel—coronary artery disease	0.000141	0.000986	CcSEcCtD
Lisuride—Gastrointestinal disorder—Furosemide—coronary artery disease	0.00014	0.000984	CcSEcCtD
Lisuride—Fatigue—Furosemide—coronary artery disease	0.00014	0.000983	CcSEcCtD
Lisuride—Dyspnoea—Losartan—coronary artery disease	0.00014	0.000981	CcSEcCtD
Lisuride—Anxiety—Ramipril—coronary artery disease	0.00014	0.000981	CcSEcCtD
Lisuride—Vomiting—Lovastatin—coronary artery disease	0.00014	0.000979	CcSEcCtD
Lisuride—Somnolence—Losartan—coronary artery disease	0.000139	0.000978	CcSEcCtD
Lisuride—Dizziness—Eplerenone—coronary artery disease	0.000139	0.000978	CcSEcCtD
Lisuride—Asthenia—Valsartan—coronary artery disease	0.000139	0.000976	CcSEcCtD
Lisuride—Constipation—Furosemide—coronary artery disease	0.000139	0.000975	CcSEcCtD
Lisuride—Asthenia—Olmesartan—coronary artery disease	0.000139	0.000971	CcSEcCtD
Lisuride—Headache—Clopidogrel—coronary artery disease	0.000139	0.000971	CcSEcCtD
Lisuride—Feeling abnormal—Perindopril—coronary artery disease	0.000138	0.000967	CcSEcCtD
Lisuride—Headache—Lovastatin—coronary artery disease	0.000138	0.000965	CcSEcCtD
Lisuride—Dry mouth—Ramipril—coronary artery disease	0.000137	0.000962	CcSEcCtD
Lisuride—Vomiting—Ezetimibe—coronary artery disease	0.000137	0.00096	CcSEcCtD
Lisuride—Anxiety—Timolol—coronary artery disease	0.000137	0.000959	CcSEcCtD
Lisuride—Decreased appetite—Losartan—coronary artery disease	0.000136	0.000956	CcSEcCtD
Lisuride—Dizziness—Simvastatin—coronary artery disease	0.000136	0.000953	CcSEcCtD
Lisuride—Confusional state—Ramipril—coronary artery disease	0.000136	0.000951	CcSEcCtD
Lisuride—Asthenia—Niacin—coronary artery disease	0.000135	0.000949	CcSEcCtD
Lisuride—Fatigue—Losartan—coronary artery disease	0.000135	0.000948	CcSEcCtD
Lisuride—Headache—Ezetimibe—coronary artery disease	0.000135	0.000946	CcSEcCtD
Lisuride—Vertigo—Lisinopril—coronary artery disease	0.000134	0.000942	CcSEcCtD
Lisuride—Dry mouth—Timolol—coronary artery disease	0.000134	0.000941	CcSEcCtD
Lisuride—Constipation—Losartan—coronary artery disease	0.000134	0.000941	CcSEcCtD
Lisuride—Syncope—Lisinopril—coronary artery disease	0.000134	0.00094	CcSEcCtD
Lisuride—Vomiting—Eplerenone—coronary artery disease	0.000134	0.00094	CcSEcCtD
Lisuride—Feeling abnormal—Furosemide—coronary artery disease	0.000134	0.00094	CcSEcCtD
Lisuride—Asthenia—Pravastatin—coronary artery disease	0.000133	0.000934	CcSEcCtD
Lisuride—Confusional state—Timolol—coronary artery disease	0.000133	0.00093	CcSEcCtD
Lisuride—Palpitations—Lisinopril—coronary artery disease	0.000132	0.000926	CcSEcCtD
Lisuride—Headache—Eplerenone—coronary artery disease	0.000132	0.000926	CcSEcCtD
Lisuride—Nervous system disorder—Ramipril—coronary artery disease	0.000132	0.000925	CcSEcCtD
Lisuride—Tachycardia—Ramipril—coronary artery disease	0.000131	0.000921	CcSEcCtD
Lisuride—Infection—Timolol—coronary artery disease	0.000131	0.000916	CcSEcCtD
Lisuride—Vomiting—Simvastatin—coronary artery disease	0.000131	0.000916	CcSEcCtD
Lisuride—Cough—Lisinopril—coronary artery disease	0.00013	0.000915	CcSEcCtD
Lisuride—Hyperhidrosis—Ramipril—coronary artery disease	0.00013	0.000912	CcSEcCtD
Lisuride—Asthenia—Trandolapril—coronary artery disease	0.000129	0.000907	CcSEcCtD
Lisuride—Feeling abnormal—Losartan—coronary artery disease	0.000129	0.000907	CcSEcCtD
Lisuride—Nervous system disorder—Timolol—coronary artery disease	0.000129	0.000904	CcSEcCtD
Lisuride—Asthenia—Enalapril—coronary artery disease	0.000129	0.000904	CcSEcCtD
Lisuride—Headache—Simvastatin—coronary artery disease	0.000129	0.000902	CcSEcCtD
Lisuride—Dizziness—Valsartan—coronary artery disease	0.000128	0.0009	CcSEcCtD
Lisuride—Anorexia—Ramipril—coronary artery disease	0.000128	0.000899	CcSEcCtD
Lisuride—Dizziness—Olmesartan—coronary artery disease	0.000128	0.000895	CcSEcCtD
Lisuride—Hyperhidrosis—Timolol—coronary artery disease	0.000127	0.000892	CcSEcCtD
Lisuride—Asthenia—Telmisartan—coronary artery disease	0.000127	0.000891	CcSEcCtD
Lisuride—Anxiety—Lisinopril—coronary artery disease	0.000127	0.000889	CcSEcCtD
Lisuride—Anorexia—Timolol—coronary artery disease	0.000125	0.000879	CcSEcCtD
Lisuride—Dizziness—Niacin—coronary artery disease	0.000125	0.000875	CcSEcCtD
Lisuride—Dry mouth—Lisinopril—coronary artery disease	0.000124	0.000873	CcSEcCtD
Lisuride—Asthenia—Captopril—coronary artery disease	0.000124	0.000867	CcSEcCtD
Lisuride—Vomiting—Valsartan—coronary artery disease	0.000123	0.000865	CcSEcCtD
Lisuride—Confusional state—Lisinopril—coronary artery disease	0.000123	0.000863	CcSEcCtD
Lisuride—Dizziness—Pravastatin—coronary artery disease	0.000123	0.000861	CcSEcCtD
Lisuride—Vomiting—Olmesartan—coronary artery disease	0.000123	0.000861	CcSEcCtD
Lisuride—Insomnia—Ramipril—coronary artery disease	0.000122	0.000853	CcSEcCtD
Lisuride—Headache—Valsartan—coronary artery disease	0.000122	0.000852	CcSEcCtD
Lisuride—Infection—Lisinopril—coronary artery disease	0.000121	0.00085	CcSEcCtD
Lisuride—Headache—Olmesartan—coronary artery disease	0.000121	0.000848	CcSEcCtD
Lisuride—Asthenia—Perindopril—coronary artery disease	0.00012	0.000842	CcSEcCtD
Lisuride—Dyspnoea—Ramipril—coronary artery disease	0.00012	0.000841	CcSEcCtD
Lisuride—Vomiting—Niacin—coronary artery disease	0.00012	0.000841	CcSEcCtD
Lisuride—Somnolence—Ramipril—coronary artery disease	0.00012	0.000839	CcSEcCtD
Lisuride—Dizziness—Trandolapril—coronary artery disease	0.000119	0.000836	CcSEcCtD
Lisuride—Tachycardia—Lisinopril—coronary artery disease	0.000119	0.000835	CcSEcCtD
Lisuride—Insomnia—Timolol—coronary artery disease	0.000119	0.000834	CcSEcCtD
Lisuride—Dizziness—Enalapril—coronary artery disease	0.000119	0.000833	CcSEcCtD
Lisuride—Headache—Niacin—coronary artery disease	0.000118	0.000829	CcSEcCtD
Lisuride—Vomiting—Pravastatin—coronary artery disease	0.000118	0.000828	CcSEcCtD
Lisuride—Hyperhidrosis—Lisinopril—coronary artery disease	0.000118	0.000827	CcSEcCtD
Lisuride—Dyspnoea—Timolol—coronary artery disease	0.000117	0.000822	CcSEcCtD
Lisuride—Dizziness—Telmisartan—coronary artery disease	0.000117	0.000822	CcSEcCtD
Lisuride—Decreased appetite—Ramipril—coronary artery disease	0.000117	0.00082	CcSEcCtD
Lisuride—Somnolence—Timolol—coronary artery disease	0.000117	0.00082	CcSEcCtD
Lisuride—Asthenia—Furosemide—coronary artery disease	0.000117	0.000818	CcSEcCtD
Lisuride—Headache—Pravastatin—coronary artery disease	0.000116	0.000816	CcSEcCtD
Lisuride—Anorexia—Lisinopril—coronary artery disease	0.000116	0.000815	CcSEcCtD
Lisuride—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000116	0.000814	CcSEcCtD
Lisuride—Fatigue—Ramipril—coronary artery disease	0.000116	0.000813	CcSEcCtD
Lisuride—Constipation—Ramipril—coronary artery disease	0.000115	0.000807	CcSEcCtD
Lisuride—Vomiting—Trandolapril—coronary artery disease	0.000115	0.000804	CcSEcCtD
Lisuride—Decreased appetite—Timolol—coronary artery disease	0.000114	0.000802	CcSEcCtD
Lisuride—Vomiting—Enalapril—coronary artery disease	0.000114	0.000801	CcSEcCtD
Lisuride—Dizziness—Captopril—coronary artery disease	0.000114	0.000799	CcSEcCtD
Lisuride—Gastrointestinal disorder—Timolol—coronary artery disease	0.000114	0.000796	CcSEcCtD
Lisuride—Fatigue—Timolol—coronary artery disease	0.000113	0.000795	CcSEcCtD
Lisuride—Headache—Trandolapril—coronary artery disease	0.000113	0.000792	CcSEcCtD
Lisuride—Vomiting—Telmisartan—coronary artery disease	0.000113	0.00079	CcSEcCtD
Lisuride—Asthenia—Losartan—coronary artery disease	0.000113	0.000789	CcSEcCtD
Lisuride—Headache—Enalapril—coronary artery disease	0.000113	0.000789	CcSEcCtD
Lisuride—Headache—Telmisartan—coronary artery disease	0.000111	0.000778	CcSEcCtD
Lisuride—Feeling abnormal—Ramipril—coronary artery disease	0.000111	0.000777	CcSEcCtD
Lisuride—Dizziness—Perindopril—coronary artery disease	0.000111	0.000776	CcSEcCtD
Lisuride—Insomnia—Lisinopril—coronary artery disease	0.00011	0.000774	CcSEcCtD
Lisuride—Vomiting—Captopril—coronary artery disease	0.00011	0.000768	CcSEcCtD
Lisuride—Dyspnoea—Lisinopril—coronary artery disease	0.000109	0.000763	CcSEcCtD
Lisuride—Somnolence—Lisinopril—coronary artery disease	0.000108	0.000761	CcSEcCtD
Lisuride—Feeling abnormal—Timolol—coronary artery disease	0.000108	0.00076	CcSEcCtD
Lisuride—Headache—Captopril—coronary artery disease	0.000108	0.000757	CcSEcCtD
Lisuride—Dizziness—Furosemide—coronary artery disease	0.000108	0.000754	CcSEcCtD
Lisuride—Vomiting—Perindopril—coronary artery disease	0.000106	0.000746	CcSEcCtD
Lisuride—Decreased appetite—Lisinopril—coronary artery disease	0.000106	0.000744	CcSEcCtD
Lisuride—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000105	0.000739	CcSEcCtD
Lisuride—Fatigue—Lisinopril—coronary artery disease	0.000105	0.000738	CcSEcCtD
Lisuride—Headache—Perindopril—coronary artery disease	0.000105	0.000735	CcSEcCtD
Lisuride—Constipation—Lisinopril—coronary artery disease	0.000104	0.000732	CcSEcCtD
Lisuride—Dizziness—Losartan—coronary artery disease	0.000104	0.000727	CcSEcCtD
Lisuride—Vomiting—Furosemide—coronary artery disease	0.000103	0.000725	CcSEcCtD
Lisuride—Headache—Furosemide—coronary artery disease	0.000102	0.000714	CcSEcCtD
Lisuride—Feeling abnormal—Lisinopril—coronary artery disease	0.000101	0.000705	CcSEcCtD
Lisuride—Vomiting—Losartan—coronary artery disease	9.98e-05	0.000699	CcSEcCtD
Lisuride—Headache—Losartan—coronary artery disease	9.83e-05	0.000689	CcSEcCtD
Lisuride—Asthenia—Ramipril—coronary artery disease	9.65e-05	0.000677	CcSEcCtD
Lisuride—Asthenia—Timolol—coronary artery disease	9.44e-05	0.000662	CcSEcCtD
Lisuride—Dizziness—Ramipril—coronary artery disease	8.9e-05	0.000624	CcSEcCtD
Lisuride—Asthenia—Lisinopril—coronary artery disease	8.75e-05	0.000614	CcSEcCtD
Lisuride—Dizziness—Timolol—coronary artery disease	8.7e-05	0.00061	CcSEcCtD
Lisuride—Vomiting—Ramipril—coronary artery disease	8.55e-05	0.0006	CcSEcCtD
Lisuride—Headache—Ramipril—coronary artery disease	8.43e-05	0.000591	CcSEcCtD
Lisuride—Vomiting—Timolol—coronary artery disease	8.36e-05	0.000586	CcSEcCtD
Lisuride—Headache—Timolol—coronary artery disease	8.24e-05	0.000578	CcSEcCtD
Lisuride—Dizziness—Lisinopril—coronary artery disease	8.07e-05	0.000566	CcSEcCtD
Lisuride—Vomiting—Lisinopril—coronary artery disease	7.76e-05	0.000544	CcSEcCtD
Lisuride—Headache—Lisinopril—coronary artery disease	7.64e-05	0.000536	CcSEcCtD
Lisuride—CYP2D6—Metabolism—GPX1—coronary artery disease	1.69e-06	1.18e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.68e-06	1.18e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	1.68e-06	1.18e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCND1—coronary artery disease	1.68e-06	1.18e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.68e-06	1.18e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.68e-06	1.17e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	1.67e-06	1.17e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.67e-06	1.17e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.67e-06	1.17e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—JAK2—coronary artery disease	1.67e-06	1.17e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—NOS3—coronary artery disease	1.66e-06	1.17e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	1.16e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—VEGFA—coronary artery disease	1.65e-06	1.15e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.64e-06	1.15e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CD36—coronary artery disease	1.64e-06	1.15e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	1.64e-06	1.15e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MMP9—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CTGF—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.63e-06	1.14e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.62e-06	1.13e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.61e-06	1.13e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GOT2—coronary artery disease	1.61e-06	1.13e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.61e-06	1.13e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.61e-06	1.12e-05	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.6e-06	1.12e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—AKT1—coronary artery disease	1.6e-06	1.12e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.6e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.6e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.6e-06	1.12e-05	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.59e-06	1.11e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	1.58e-06	1.11e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—AKT1—coronary artery disease	1.58e-06	1.11e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.58e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.57e-06	1.1e-05	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.57e-06	1.1e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.57e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.57e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.57e-06	1.1e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.56e-06	1.09e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.56e-06	1.09e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.56e-06	1.09e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.56e-06	1.09e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.56e-06	1.09e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.56e-06	1.09e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.55e-06	1.09e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.55e-06	1.09e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.55e-06	1.08e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—coronary artery disease	1.54e-06	1.08e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.54e-06	1.08e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.54e-06	1.08e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.54e-06	1.08e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.53e-06	1.07e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.53e-06	1.07e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.53e-06	1.07e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.52e-06	1.07e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	1.52e-06	1.06e-05	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.52e-06	1.06e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.52e-06	1.06e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TGFB1—coronary artery disease	1.51e-06	1.06e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.51e-06	1.06e-05	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.51e-06	1.06e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.51e-06	1.06e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.5e-06	1.05e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.5e-06	1.05e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.5e-06	1.05e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.49e-06	1.05e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.49e-06	1.04e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.49e-06	1.04e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.49e-06	1.04e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.48e-06	1.04e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	1.04e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MAPK1—coronary artery disease	1.48e-06	1.04e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.48e-06	1.04e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AGT—coronary artery disease	1.48e-06	1.03e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.47e-06	1.03e-05	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	1.47e-06	1.03e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	1.46e-06	1.03e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—VEGFA—coronary artery disease	1.46e-06	1.03e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.46e-06	1.02e-05	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.46e-06	1.02e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.46e-06	1.02e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.46e-06	1.02e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.46e-06	1.02e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	1.45e-06	1.02e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—coronary artery disease	1.45e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	1.45e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.45e-06	1.01e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.44e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.44e-06	1.01e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.44e-06	1.01e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.43e-06	1e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOA1—coronary artery disease	1.43e-06	1e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.43e-06	1e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AKT1—coronary artery disease	1.42e-06	9.98e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.42e-06	9.96e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.42e-06	9.95e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.42e-06	9.92e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	1.42e-06	9.92e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.41e-06	9.9e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.41e-06	9.88e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GGT1—coronary artery disease	1.39e-06	9.76e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GOT1—coronary artery disease	1.39e-06	9.76e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.39e-06	9.76e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.39e-06	9.75e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.38e-06	9.66e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.38e-06	9.65e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	1.37e-06	9.63e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.37e-06	9.6e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	9.54e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.36e-06	9.5e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	1.35e-06	9.48e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.35e-06	9.47e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	1.34e-06	9.41e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—coronary artery disease	1.34e-06	9.41e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	1.34e-06	9.36e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MAPK1—coronary artery disease	1.34e-06	9.35e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.33e-06	9.34e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	1.33e-06	9.34e-06	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.33e-06	9.33e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.33e-06	9.28e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	1.32e-06	9.26e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.32e-06	9.24e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	1.32e-06	9.23e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MAPK1—coronary artery disease	1.32e-06	9.23e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	1.31e-06	9.19e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.31e-06	9.18e-06	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.31e-06	9.18e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-06	9.16e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.3e-06	9.1e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.29e-06	9.04e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	1.29e-06	9.01e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.28e-06	9e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.28e-06	8.93e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.27e-06	8.89e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.26e-06	8.85e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARG—coronary artery disease	1.26e-06	8.83e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.25e-06	8.77e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.25e-06	8.74e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—POMC—coronary artery disease	1.24e-06	8.71e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.24e-06	8.69e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.23e-06	8.65e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	1.23e-06	8.65e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	1.23e-06	8.65e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	1.23e-06	8.6e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.23e-06	8.6e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.22e-06	8.57e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CAT—coronary artery disease	1.22e-06	8.53e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	1.21e-06	8.51e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	1.21e-06	8.49e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.21e-06	8.47e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.2e-06	8.41e-06	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.19e-06	8.35e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.19e-06	8.34e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	1.19e-06	8.33e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—coronary artery disease	1.18e-06	8.28e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOB—coronary artery disease	1.18e-06	8.28e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.18e-06	8.27e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.17e-06	8.22e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.17e-06	8.2e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.16e-06	8.16e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	8.11e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—coronary artery disease	1.16e-06	8.11e-06	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PIK3CA—coronary artery disease	1.15e-06	8.08e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.15e-06	8.06e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.15e-06	8.05e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.15e-06	8.04e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	1.14e-06	8.01e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	1.14e-06	8.01e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.14e-06	8e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—coronary artery disease	1.14e-06	7.98e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—coronary artery disease	1.13e-06	7.94e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	1.13e-06	7.93e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—LPL—coronary artery disease	1.13e-06	7.91e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.12e-06	7.84e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.12e-06	7.82e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	1.12e-06	7.81e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	1.11e-06	7.78e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.1e-06	7.72e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GPX1—coronary artery disease	1.1e-06	7.72e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	1.09e-06	7.66e-06	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.09e-06	7.64e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—coronary artery disease	1.09e-06	7.62e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—NOS3—coronary artery disease	1.08e-06	7.6e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.08e-06	7.58e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CD36—coronary artery disease	1.07e-06	7.51e-06	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.07e-06	7.48e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.06e-06	7.42e-06	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AKT1—coronary artery disease	1.05e-06	7.36e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-06	7.3e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	1.03e-06	7.23e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—coronary artery disease	1.03e-06	7.2e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—coronary artery disease	1.03e-06	7.19e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.02e-06	7.12e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—coronary artery disease	1.01e-06	7.09e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—coronary artery disease	1.01e-06	7.09e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.01e-06	7.08e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MAPK1—coronary artery disease	1.01e-06	7.06e-06	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AKT1—coronary artery disease	1e-06	7.03e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1e-06	7.02e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	9.96e-07	6.98e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	9.92e-07	6.95e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—coronary artery disease	9.92e-07	6.95e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	9.91e-07	6.94e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AGT—coronary artery disease	9.66e-07	6.77e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	9.64e-07	6.75e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	9.49e-07	6.65e-06	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AKT1—coronary artery disease	9.47e-07	6.63e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—coronary artery disease	9.47e-07	6.63e-06	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AKT1—coronary artery disease	9.42e-07	6.6e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PIK3CA—coronary artery disease	9.37e-07	6.56e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOA1—coronary artery disease	9.36e-07	6.55e-06	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	9.34e-07	6.54e-06	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AKT1—coronary artery disease	9.34e-07	6.54e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—coronary artery disease	9.22e-07	6.46e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	9.2e-07	6.45e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—coronary artery disease	9.14e-07	6.4e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	9.03e-07	6.32e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—coronary artery disease	8.82e-07	6.18e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—coronary artery disease	8.78e-07	6.15e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	8.75e-07	6.13e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	8.61e-07	6.03e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—coronary artery disease	8.54e-07	5.98e-06	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKT1—coronary artery disease	8.51e-07	5.96e-06	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	8.43e-07	5.91e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—coronary artery disease	8.4e-07	5.88e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARG—coronary artery disease	8.24e-07	5.77e-06	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKT1—coronary artery disease	8.14e-07	5.7e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—POMC—coronary artery disease	8.13e-07	5.69e-06	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKT1—coronary artery disease	8.1e-07	5.67e-06	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	7.88e-07	5.52e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	7.83e-07	5.48e-06	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	7.75e-07	5.43e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—coronary artery disease	7.75e-07	5.43e-06	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AKT1—coronary artery disease	7.65e-07	5.36e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—coronary artery disease	7.62e-07	5.34e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—coronary artery disease	7.41e-07	5.19e-06	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKT1—coronary artery disease	7.15e-07	5.01e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NOS3—coronary artery disease	7.09e-07	4.97e-06	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKT1—coronary artery disease	7.03e-07	4.92e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—coronary artery disease	6.93e-07	4.86e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—coronary artery disease	6.49e-07	4.54e-06	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	6.4e-07	4.48e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.1e-07	4.27e-06	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AKT1—coronary artery disease	4.99e-07	3.49e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.99e-07	2.79e-06	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AKT1—coronary artery disease	3.26e-07	2.28e-06	CbGpPWpGaD
